|
RBL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.61790000180662E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11759999979577E-07 |
| Normal-vs-Stage2 |
3.19649999802607E-08 |
| Normal-vs-Stage3 |
1.65590000045235E-07 |
| Normal-vs-Stage4 |
2.50700005199889E-09 |
| Stage1-vs-Stage2 |
1.299380E-01 |
| Stage1-vs-Stage3 |
7.035000E-01 |
| Stage1-vs-Stage4 |
2.092400E-02 |
| Stage2-vs-Stage3 |
2.844400E-01 |
| Stage2-vs-Stage4 |
7.165600E-01 |
| Stage3-vs-Stage4 |
1.225820E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.21590000079897E-08 |
| Normal-vs-AfricanAmerican |
5.437900E-04 |
| Normal-vs-Asian |
8.09809999946509E-07 |
| Caucasian-vs-AfricanAmerican |
7.407600E-01 |
| Caucasian-vs-Asian |
8.402400E-01 |
| AfricanAmerican-vs-Asian |
6.635200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.06829997573266E-09 |
| Normal-vs-Female |
7.57610000290398E-08 |
| Male-vs-Female |
3.517200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.77180000004995E-06 |
| Normal-vs-Age(41-60Yrs) |
6.39980290983999E-11 |
| Normal-vs-Age(61-80Yrs) |
9.47269995776878E-09 |
| Normal-vs-Age(81-100Yrs) |
1.360610E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.391600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.312100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.400200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.013200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.629000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.918200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.180210E-01 |
| Classical-VS-Follicular |
1.890140E-02 |
| Classical-VS-Other |
4.229000E-01 |
| Classical-VS-Normal |
9.29839999996851E-07 |
| Tall-VS-Follicular |
9.891200E-01 |
| Tall-VS-Other |
9.948000E-01 |
| Tall-VS-Normal |
1.40749999988365E-07 |
| Follicular-VS-Other |
9.995200E-01 |
| Follicular-VS-Normal |
2.7133000291002E-09 |
| Other-VS-Normal |
1.154040E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.77979869625733E-11 |
| Normal-vs-N1 |
4.91170000005425E-07 |
| N0-vs-N1 |
8.870000E-01 |
|
|
